Fig. 2From: Prophylactic treatment with oral azithromycin in cancer patients during the COVID-19 pandemic (OnCoVID): a randomized, single-blinded, placebo-controlled phase 2 trialOverall survival of the mITT population in the azithromycin and placebo groupsBack to article page